AbCellera Biologics (ABCL) Other financing activities (2020 - 2024)
AbCellera Biologics' (ABCL) quarterly Other financing activities came in at $227000.0 in Q3 2024, down 11.33% YoY from $256000.0 in Q4 2023, and down 50.76% on a QoQ basis from $461000.0 in Q2 2024.
AbCellera Biologics (ABCL) Other financing activities (2020 - 2024) Analysis & Trends
AbCellera Biologics (ABCL) has 4 years of Other financing activities data on file, last reported at $227000.0 in Q3 2024.
- Quarterly Other financing activities fell 11.33% year-over-year to $227000.0 in Q3 2024, while the trailing twelve-month figure through Sep 2024 was $1.8 million (down 36.99% YoY) and the FY2021 annual result came in at $4.6 million, up 361.5% from the prior year.
- Other financing activities fell to $227000.0 in Q3 2024, from $461000.0 in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $1.8 million in Q4 2021 to a low of -$548000.0 in Q2 2020.
- A 4-year average of $591071.4 and a median of $475500.0 in 2023 frame the typical range for Other financing activities.
- The widest YoY moves for Other financing activities: up 1614.02% in 2021, down 78.35% in 2021.
- Tracing ABCL's Other financing activities over 4 years: stood at $107000.0 in 2020, then jumped by 1614.02% to $1.8 million in 2021, then sank by 86.04% to $256000.0 in 2023, then declined by 11.33% to $227000.0 in 2024.
- The last three Other financing activities figures came in at $227000.0 (Q3 2024), $461000.0 (Q2 2024), and $892000.0 (Q1 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | AbCellera Biologics | 3.49 Bn | 3.49 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 227,000.00 |
| Sep 30, 2024 | 227,000.00 |
| Jun 30, 2024 | 461,000.00 |
| Jun 30, 2024 | 461,000.00 |
| Mar 31, 2024 | 892,000.00 |
| Mar 31, 2024 | 892,000.00 |
| Sep 30, 2023 | 256,000.00 |
| Sep 30, 2023 | 256,000.00 |
| Jun 30, 2023 | 334,000.00 |
| Jun 30, 2023 | 334,000.00 |
| Mar 31, 2023 | 490,000.00 |
| Mar 31, 2023 | 490,000.00 |
| Dec 31, 2021 | 1.83 Mn |
| Dec 31, 2021 | 1.83 Mn |
| Sep 30, 2021 | 898,000.00 |
| Sep 30, 2021 | 898,000.00 |
| Jun 30, 2021 | 1.71 Mn |
| Jun 30, 2021 | 1.71 Mn |
| Mar 31, 2021 | 173,000.00 |
| Mar 31, 2021 | 173,000.00 |